The expression levels of these proteins have previously been investigated in breast cancer, with results indicating that expression of calpain-1 is associated with relapse-free survival in HER2 positive breast cancer patients treated with trastuzumab following adjuvant chemotherapy [17]. Here, ERBB2 is linked to breast cancer.